Clinical Trial: DR-01-ONC-001

Trial Status: Open
Disease Types: Leukemia, Lymphoma
Trial ID DR-01-ONC-001
Sponsor ID Dren Bio

A Multicenter, Open-Label, First-in-Human, Multiple Expansion Cohort, Phase 1/2 Study to Evaluate the Safety and Efficacy of DR-01 in Adult Subjects with Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas


Fairfax Office

Learn More About This Trial

Other Relevant Trials
Trial ID 22041
Sponsor ID M23-362

A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab monotherapy in Subjects with Relapsed or Refractory Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 1-3a when Administered in the Outpatient Setting (M23-362)

Principal Investigator
Mitul Gandhi, MD
3 Locations
Trial ID 21287
Sponsor ID Novartis

A phase Ib/II open label dose confirmation, proof of concept study of siremadlin in combination with venetoclax plus azacitidine in unfit adult AML participants who responded sub-optimally to first-line venetoclax plus azacitidine treatment and in participants with newly diagnosed unfit AML presenting with high-risk clinical features (CHDM201I12201)

Principal Investigator
Mitul Gandhi, MD
1 Location